Condition: Congenital Sucrase-Isomaltase Deficiency · CSID · Sucrase Isomaltase Deficiency · Sponsor: QOL Medical, LLC
This is a Phase 4, U.S. only, multi-center study using a 7-day therapeutic response dose (TRD) of commercial Sucraid® to assess the response of treatment in 1100 symptomatic pediatric (6 months to 17 years old) subjects with low, moderate, and normal sucrase activity determined by a disaccharidase assay via EGD within 1 year of the Screening Visit. This study will also explore the relationship between known genetic CSID mutations and sucrase activities via (EGD) disaccharidase assay (low, moderate, and normal).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| UCSF Benioff Children's Hospital Oakland | Oakland, California, United States | — |
| Kidz Medical | Coral Gables, Florida, United States | — |
| Orlando Health | Orlando, Florida, United States | — |
| Children's Healthcare of Atlanta | Atlanta, Georgia, United States | — |
| Center for Digestive Health Care, LLC | Atlanta, Georgia, United States | — |
| University of Maryland Baltimore | Baltimore, Maryland, United States | — |
| Johns Hopkins University | Baltimore, Maryland, United States | — |
| GI Associates | Flowood, Mississippi, United States | — |
| Happy Tummies | Flowood, Mississippi, United States | — |
| Children's Mercy Hospital | Kansas City, Missouri, United States | — |
| Atlantic Health System | Morristown, New Jersey, United States | — |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05480761